Erivedge (Vismodegib) in the Treatment of Pediatric Patients With Refractory Pontine Glioma
Status:
Terminated
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate an investigational drug (Vismodegib) for
Pontine Glioma that is growing or has come back (reoccurred). This study will look at the
tumors response to the study drug, Vismodegib, and will also look at the safety and
tolerability of Vismodegib.
Vismodegib has been tested in multiple adult clinical trials and one pediatric trial.
Laboratory testing in pontine gliomas suggests that this drug may be effective in treating
this disease.
Phase:
Phase 2
Details
Lead Sponsor:
Giselle SaulnierSholler Giselle Sholler
Collaborators:
Phoenix Children's Hospital Spectrum Health Hospitals